Impel Pharmaceuticals changes name to IPI Legacy Liquidation Co effective March 8, 2024

IMPEL PHARMACEUTICALS INC

Name changed from Impel Pharmaceuticals Inc. to IPI Legacy Liquidation Co via certificate of amendment.
Name change did not require stockholder approval under Delaware General Corporation Law.
Common stock trades on OTC Pink under symbol IMPLQ following Nasdaq delisting.
Certificate of Amendment filed as Exhibit 3.1 to the 8-K.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

IMPEL PHARMACEUTICALS INC: Company changed name to IPI Legacy Liquidation Co via a certificate of amendment to the certificate of incorporation (effective 2024-03-08).

Change: charter amendment
Effective: 2024-03-08

Exact text from the filing

Effective as of March 8, 2024, Impel Pharmaceuticals Inc. (the “ Company ”) changed its name to “IPI Legacy Liquidation Co” (the “ Name Change ”) pursuant to a certificate of amendment to its certificate of incorporation (the “ Certificate of Amendment ”).

View on SEC.gov

Browse all governance changes →

Source: SEC EDGAR

accession 0001193125-24-065453

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.